Goldman Sachs’s Signify Health, Inc. SGFY Stock Holding History

Goldman Sachs’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,289,299	Closed	-$65.6M	–	6388
2022 Q4	$65.6M	Buy	2,289,299 +104,389	+5%	+$3.01M	0.02%	958
2022 Q3	$63.7M	Buy	2,184,910 +1,914,318	+707%	+$44.1M	0.02%	950
2022 Q2	$3.73M	Buy	270,592 +60,583	+29%	+$853K	﹤0.01%	3454
2022 Q1	$3.81M	Buy	210,009 +100,360	+92%	+$1.44M	﹤0.01%	3615
2021 Q4	$1.56M	Sell	109,649 -68,627	-38%	-$1.06M	﹤0.01%	4459
2021 Q3	$3.19M	Buy	178,276 +147,159	+473%	+$3.78M	﹤0.01%	3765
2021 Q2	$947K	Buy	31,117 +7,067	+29%	+$194K	﹤0.01%	4805
2021 Q1	$704K	Buy	+24,050	New	+$744K	﹤0.01%	4878

Other funds holding SGFY

BHCM

Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Goldman Sachs's SGFY Position: Q1 2023 in Review

Goldman Sachs sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 2,289,299 shares — an estimated $65.6M sold.

Goldman Sachs first reported a position in SGFY in Q1 2021 and held it in 8 quarters. The position peaked at $65.6M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

Goldman Sachs reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
Goldman Sachs sold 2,289,299 Signify Health, Inc. shares in Q1 2023, an estimated $65.6M.
Goldman Sachs first reported a position in Signify Health, Inc. in Q1 2021 and held it in 8 quarters.
Goldman Sachs's Signify Health, Inc. position peaked at $65.6M in Q4 2022.
5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.